The corneal epithelial basement membrane: Structure, function, and disease

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 6390-6400

  Torricelli, André A M ^a   Singh, Vivek ^a   Santhiago, Marcony R ^b,c   Wilson, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Basement membrane; Corneal epithelium; Myofibroblasts; Wound healing

Indexed keywords

COLLAGEN TYPE 12; COLLAGEN TYPE 15; COLLAGEN TYPE 17; COLLAGEN TYPE 18; COLLAGEN TYPE 4; COLLAGEN TYPE 7; ENTACTIN; FIBRILLIN 1; FIBRONECTIN; KERATINOCYTE GROWTH FACTOR; LAMININ; PERLECAN; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TENASCIN; THROMBOSPONDIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CORNEA EPITHELIUM; DIABETES MELLITUS; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYPERPLASIA; HYPERTROPHY; KERATOCONUS; KERATOPATHY; NONHUMAN; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING;

BASEMENT MEMBRANE; CORNEAL EPITHELIUM; MYOFIBROBLASTS; WOUND HEALING;

ANIMALS; BASEMENT MEMBRANE; CORNEAL DISEASES; EPITHELIUM, CORNEAL; HUMANS;

EID: 84884796987     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12547     Document Type: Review

References (150)

1. Kruegel J, Miosge N. Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci. 2010;67:2879-2895.
2. Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays. 1996;18:123-132.
3. Merker HJ. Morphology of the basement membrane. Microsc Res Tech. 1994;28:95-124.
4. Tuori A, Uusitalo H, Burgeson RE, Terttunen J, Virtanen I. The immunohistochemical composition of the human corneal basement membrane. Cornea. 1996;15:286-294.
5. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326:1216-1219.
6. Schlotzer-Schrehardt U, Dietrich T, Saito K, et al. Characterization of extracellular matrix components in the limbal epithelial stem cell compartment. Exp Eye Res. 2007;85:845-860.
7. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol. 2004;265:23-32.
8. Russell AJ, Fincher EF, Millman L, et al. Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J Cell Sci. 2003;116:3543-3556.
9. Hamelers IH, Olivo C, Mertens AE, et al. The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration. J Cell Biol. 2005;171:871-881.
10. Hamill KJ, Kligys K, Hopkinson SB, Jones JC. Laminin deposition in the extracellular matrix: a complex picture emerges. J Cell Sci. 2009;122:4409-4417.
11. Sehgal BU, DeBiase PJ, Matzno S, et al. Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J Biol Chem. 2006;281:35487-35498.
12. Wiradjaja F, DiTommaso T, Smyth I. Basement membranes in development and disease. Birth Defects Res C Embryo Today. 2010;90:8-31.
13. Yurchenco PD. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. 2011;3:3.
14. Tisdale AS, Spurr-Michaud SJ, Rodrigues M, Hackett J, Krachmer J, Gipson IK. Development of the anchoring structures of the epithelium in rabbit and human fetal corneas. Invest Ophthalmol Vis Sci. 1988;29:727-736.
15. Sevel D, Isaacs R. A re-evaluation of corneal development. Trans Am Ophthalmol Soc. 1988;86:178-207.
16. Gipson IK, Spurr-Michaud S, Tisdale A, Keough M. Reassembly of the anchoring structures of the corneal epithelium during wound repair in the rabbit. Invest Ophthalmol Vis Sci. 1989;30:425-434.
17. Thomas T, Dziadek M. Genes coding for basement membrane glycoproteins laminin, nidogen, and collagen IV are differentially expressed in the nervous system and by epithelial, endothelial, and mesenchymal cells of the mouse embryo. Exp Cell Res. 1993;208:54-67.
18. Weiser MM, Sykes DE, Killen PD. Rat intestinal basement membrane synthesis. Epithelial versus nonepithelial contributions. Lab Invest. 1990;62:325-330.
19. Fujikawa LS, Foster CS, Gipson IK, Colvin RB. Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies. J Cell Biol. 1984;98:128-138.
20. Sta Iglesia DD, Stepp MA. Disruption of the basement membrane after corneal debridement. Invest Ophthalmol Vis Sci. 2000;41:1045-1053.
21. Torricelli AA, Singh V, Agrawal V, Santhiago MR, Wilson SE. Transmission electron microscopy analysis of epithelial basement membrane repair in rabbit corneas with haze. Invest Ophthalmol Vis Sci. 2013;54:4026-4033.
22. Kabosova A, Azar DT, Bannikov GA, et al. Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci. 2007;48:4989-4999.
23. Kolega J, Manabe M, Sun TT. Basement membrane heterogeneity and variation in corneal epithelial differentiation. Differentiation. 1989;42:54-63.
24. Marshall GE, Konstas AG, Lee WR. Immunogold fine structural localization of extracellular matrix components in aged human cornea. II. Collagen types V and VI. Graefes Arch Clin Exp Ophthalmol. 1991;229:164-171.
25. Odermatt BF, Lang AB, Ruttner JR, Winterhalter KH, Trueb B. Monoclonal antibodies to human type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci U S A. 1984;81:7343-7347.
26. Scheinman JI, Tsai C. Monoclonal antibody to type IV collagen with selective basement membrane localization. Lab Invest. 1984;50:101-112.
27. Konomi H, Hayashi T, Nakayasu K, Arima M. Localization of type V collagen and type IV collagen in human cornea, lung, and skin. Immunohistochemical evidence by anti-collagen antibodies characterized by immunoelectroblotting. Am J Pathol. 1984;116:417-426.
28. Marshall GE, Konstas AG, Lee WR. Collagens in ocular tissues. Br J Ophthalmol. 1993;77:515-524.
29. Nakayasu K, Tanaka M, Konomi H, Hayashi T. Distribution of types I, II, III, IV and V collagen in normal and keratoconus corneas. Ophthalmic Res. 1986;18:1-10.
30. Tsuchiya S, Tanaka M, Konomi H, Hayashi T. Distribution of specific collagen types and fibronectin in normal and keratoconus corneas. Jpn J Ophthalmol. 1986;30:14-31.
31. Cleutjens JP, Havenith MG, Kasper M, Vallinga M, Bosman FT. Absence of type IV collagen in the centre of the corneal epithelial basement membrane. Histochem J. 1990;22:688-694.
32. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun TT, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 1995;72:461-473.
33. Khoshnoodi J, Pedchenko V, Hudson BG. Mammalian collagen IV. Microsc Res Tech. 2008;71:357-370.
34. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol. 2004;15:2514-2527.
35. Sakai LY, Keene DR, Morris NP, Burgeson RE. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol. 1986;103:1577-1586.
36. Maatta M, Heljasvaara R, Sormunen R, Pihlajaniemi T, Autio-Harmainen H, Tervo T. Differential expression of collagen types XVIII/endostatin and XV in normal, keratoconus, and scarred human corneas. Cornea. 2006;25:341-349.
37. Kato T, Chang JH, Azar DT. Expression of type XVIII collagen during healing of corneal incisions and keratectomy wounds. Invest Ophthalmol Vis Sci. 2003;44:78-85.
38. Saika S, Okada Y, Miyamoto T, et al. Protein expression pattern of collagen type XV in mouse cornea. Graefes Arch Clin Exp Ophthalmol. 2004;242:432-436.
39. Sasaki T, Fukai N, Mann K, Gohring W, Olsen BR, Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 1998;17:4249-4256.
40. Sasaki T, Larsson H, Tisi D, Claesson-Welsh L, Hohenester E, Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol. 2000;301:1179-1190.
41. Gordon MK, Fitch JM, Foley JW, et al. Type XVII collagen (BP 180) in the developing avian cornea. Invest Ophthalmol Vis Sci. 1997;38:153-166.
42. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem. 1998;273:9711-9717.
43. Wessel H, Anderson S, Fite D, Halvas E, Hempel J, SundarRaj N. Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices. Invest Ophthalmol Vis Sci. 1997;38:2408-2422.
44. Akimoto Y, Yamakawa N, Furukawa K, Kimata K, Kawakami H, Hirano H. Changes in distribution of the long form of type XII collagen during chicken corneal development. J Histochem Cytochem. 2002;50:851-862.
45. Massoudi D, Malecaze F, Soler V, et al. NC1 long and NC3 short splice variants of type XII collagen are overexpressed during corneal scarring. Invest Ophthalmol Vis Sci. 2012;53: 7246-7256.
46. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004;20:255-284.
47. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol. 1994;14:209-211.
48. Aumailley M, Bruckner-Tuderman L, Carter WG, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24:326-332.
49. Bystrom B, Virtanen I, Rousselle P, Miyazaki K, Linden C, Pedrosa Domellof F. Laminins in normal, keratoconus, bullous keratopathy and scarred human corneas. Histochem Cell Biol. 2007;127:657-667.
50. Ebihara N, Watanabe Y, Nakayasu K, Kanai A. The expression of laminin-5 and ultrastructure of the interface between basal cells and underlying stroma in the keratoconus cornea. Jpn J Ophthalmol. 2001;45:209-215.
51. Gilmour TK, Meyer PA, Rytina E, Todd PM. Antiepiligrin (laminin 5) cicatricial pemphigoid complicated and exacerbated by herpes simplex virus type 2 infection. Australas J Dermatol. 2001;42:271-274.
52. Zenker M, Aigner T, Wendler O, et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet. 2004;13:2625-2632.
53. Yurchenco PD, Cheng YS, Colognato H. Laminin forms an independent network in basement membranes. J Cell Biol. 1992;117:1119-1133.
54. Miner JH. Laminins and their roles in mammals. Microsc Res Tech. 2008;71:349-356.
55. Smyth N, Vatansever HS, Murray P, et al. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol. 1999;144:151-160.
56. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 1994;79:1005-1013.
57. Mongiat M, Taylor K, Otto J, et al. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem. 2000;275:7095-7100.
58. Boonen KJ, Post MJ. The muscle stem cell niche: regulation of satellite cells during regeneration. Tissue Eng Part B Rev. 2008;14:419-431.
59. Fuchs E. Finding one's niche in the skin. Cell Stem Cell. 2009; 4:499-502.
60. Iozzo RV. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol. 2005;6:646-656.
61. Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry. 2008;47: 11174-11183.
62. Nikolova G, Strilic B, Lammert E. The vascular niche and its basement membrane. Trends Cell Biol. 2007;17:19-25.
63. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat Genet. 1999;23:354-358.
64. Handler M, Yurchenco PD, Iozzo RV. Developmental expression of perlecan during murine embryogenesis. Dev Dyn. 1997;210:130-145.
65. Knox S, Melrose J, Whitelock J. Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins. Proteomics. 2001;1:1534-1541.
66. Zhou Z, Wang J, Cao R, et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 2004;64:4699-4702.
67. Sher I, Zisman-Rozen S, Eliahu L, et al. Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation. J Biol Chem. 2006;281:5178-5187.
68. Vittitow J, Borras T. Genes expressed in the human trabecular meshwork during pressure-induced homeostatic response. J Cell Physiol. 2004;201:126-137.
69. Inomata T, Ebihara N, Funaki T, et al. Perlecan-deficient mutation impairs corneal epithelial structure. Invest Ophthalmol Vis Sci. 2012;53:1277-1284.
70. Fox JW, Mayer U, Nischt R, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991;10:3137-3146.
71. Timpl R, Dziadek M, Fujiwara S, Nowack H, Wick G. Nidogen: a new, self-aggregating basement membrane protein. Eur J Biochem. 1983;137:455-465.
72. Ho MS, Bose K, Mokkapati S, Nischt R, Smyth N. Nidogensextracellular matrix linker molecules. Microsc Res Tech. 2008;71:387-395.
73. Dong L, Chen Y, Lewis M, et al. Neurologic defects and selective disruption of basement membranes in mice lacking entactin-1/nidogen-1. Lab Invest. 2002;82:1617-1630.
74. Murshed M, Smyth N, Miosge N, et al. The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol. 2000;20:7007-7012.
75. Schymeinsky J, Nedbal S, Miosge N, et al. Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice. Mol Cell Biol. 2002;22:6820-6830.
76. Miosge N, Sasaki T, Timpl R. Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice. Matrix Biol. 2002;21:611-621.
77. Maguen E, Rabinowitz YS, Regev L, Saghizadeh M, Sasaki T, Ljubimov AV. Alterations of extracellular matrix components and proteinases in human corneal buttons with INTACS for post-laser in situ keratomileusis keratectasia and keratoconus. Cornea. 2008;27:565-573.
78. Bader BL, Smyth N, Nedbal S, et al. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol. 2005;25: 6846-6856.
79. Bose K, Nischt R, Page A, Bader BL, Paulsson M, Smyth N. Loss of nidogen-1 and-2 results in syndactyly and changes in limb development. J Biol Chem. 2006;281:39620-39629.
80. Nan H, Xu M, Zhang J, et al. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet. 2011; 20:2673-2679.
81. Parikh DH, Leibl M, Tam PK, Edgar D. Abnormal expression and distribution of nidogen in Hirschsprung's disease. J Pediatr Surg. 1995;30:1687-1693.
82. Xu JM, Zhang SS, Zhang Q, et al. Ocular manifestations of Alport syndrome. Int J Ophthalmol. 2010;3:149-151.
83. Gipson IK, Spurr-Michaud SJ, Tisdale AS. Anchoring fibrils form a complex network in human and rabbit cornea. Invest Ophthalmol Vis Sci. 1987;28:212-220.
84. Zhang H, Labouesse M. The making of hemidesmosome structures in vivo. Dev Dyn. 2010;239:1465-1476.
85. Chan LS. Human skin basement membrane in health and in autoimmune diseases. Front Biosci. 1997;2:d343-d352.
86. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol. 1999;112:411-418.
87. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 1988;82:1864-1870.
88. Sawamura D, Li K, Chu ML, Uitto J. Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem. 1991; 266:17784-17790.
89. Wiche G, Becker B, Luber K, et al. Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a threedomain structure based on a central alpha-helical coiled coil. J Cell Biol. 1991;114:83-99.
90. McLean WH, Pulkkinen L, Smith FJ, et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 1996;10: 1724-1735.
91. Tanaka T, Parry DA, Klaus-Kovtun V, Steinert PM, Stanley JR. Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem. 1991;266:12555-12559.
92. Ruhrberg C, Watt FM. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev. 1997;7: 392-397.
93. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981;24:897-903.
94. Stepp MA, Spurr-Michaud S, Tisdale A, Elwell J, Gipson IK. Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci U S A. 1990;87:8970-8974.
95. Kurpakus MA, Stock EL, Jones JC. Analysis of wound healing in an in vitro model: early appearance of laminin and a 1253 10(3) Mr polypeptide during adhesion complex formation. J Cell Sci. 1990;96(pt 4):651-660.
96. Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet. 1996;13:370-373.
97. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 1996;134:559-572.
98. Burgeson RE, Christiano AM. The dermal-epidermal junction. Curr Opin Cell Biol. 1997;9:651-658.
99. Adachi E, Hopkinson I, Hayashi T. Basement-membrane stromal relationships: interactions between collagen fibrils and the lamina densa. Int Rev Cytol. 1997;173:73-156.
100. Shimizu H, Ishiko A, Masunaga T, et al. Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab Invest. 1997;76:753-763.
101. Uitto J, Pulkkinen L. Molecular complexity of the cutaneous basement membrane zone. Mol Biol Rep. 1996;23:35-46.
102. Brittingham R, Uitto J, Fertala A. High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun. 2006;343:692-699.
103. Villone D, Fritsch A, Koch M, Bruckner-Tuderman L, Hansen U, Bruckner P. Supramolecular interactions in the dermoepidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J Biol Chem. 2008;283: 24506-24513.
104. Uitto J, Christiano AM. Dystrophic forms of epidermolysis bullosa. Semin Dermatol. 1993;12:191-201.
105. Uitto J, Pulkkinen L. Molecular genetics of heritable blistering disorders. Arch Dermatol. 2001;137:1458-1461.
106. Brittingham R, Colombo M, Ito H, et al. Single amino acid substitutions in procollagen VII affect early stages of assembly of anchoring fibrils. J Biol Chem. 2005;280:191-198.
107. Fine JD, Johnson LB, Weiner M, et al. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry. Am J Ophthalmol. 2004;138: 254-262.
108. Aclimandos WA. Corneal perforation as a complication of epidermolysis bullosa acquisita. Eye (Lond). 1995;9(pt 5): 633-636.
109. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res. 2004;78:433-446.
110. Rodrigues M, Ben-Zvi A, Krachmer J, Schermer A, Sun TT. Suprabasal expression of a 64-kilodalton keratin (no. 3) in developing human corneal epithelium. Differentiation. 1987;34:60-67.
111. Schermer A, Galvin S, Sun TT. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103:49-62.
112. Chi C, Trinkaus-Randall V. New insights in wound response and repair of epithelium. J Cell Physiol. 2013;228:925-929.
113. Pal-Ghosh S, Pajoohesh-Ganji A, Tadvalkar G, Stepp MA. Removal of the basement membrane enhances corneal wound healing. Exp Eye Res. 2011;93:927-936.
114. Jester JV, Huang J, Barry-Lane PA, Kao WW, Petroll WM, Cavanagh HD. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci. 1999;40: 1959-1967.
115. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A. 1996;93:4219-4223.
116. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18:293-309.
117. Singh V, Agrawal V, Santhiago MR, Wilson SE. Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea. Exp Eye Res. 2012;98:1-8.
118. Singh V, Santhiago MR, Barbosa FL, et al. Effect of TGFbeta and PDGF-B blockade on corneal myofibroblast development in mice. Exp Eye Res. 2011;93:810-817.
119. Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea. 2005;24:S2-S11.
120. Stramer BM, Zieske JD, Jung JC, Austin JS, Fini ME. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci. 2003;44:4237-4246.
121. Wilson SE, Walker JW, Chwang EL, He YG. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
122. Wilson SE, He YG, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
123. Latvala T, Paallysaho T, Tervo K, Tervo T. Distribution of alpha 6 and beta 4 integrins following epithelial abrasion in the rabbit cornea. Acta Ophthalmol Scand. 1996;74:21-25.
124. Stepp MA, Zhu L, Cranfill R. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury. Invest Ophthalmol Vis Sci. 1996;37:1593-1601.
125. Laibson PR. Recurrent corneal erosions and epithelial basement membrane dystrophy. Eye Contact Lens. 2010;36: 315-317.
126. Resch MD, Schlotzer-Schrehardt U, Hofmann-Rummelt C, Kruse FE, Seitz B. Alterations of epithelial adhesion molecules and basement membrane components in lattice corneal dystrophy (LCD). Graefes Arch Clin Exp Ophthalmol. 2009; 247:1081-1088.
127. Colville DJ, Savige J. Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet. 1997;18:161-173.
128. Colville D, Savige J, Branley P, Wilson D. Ocular abnormalities in thin basement membrane disease. Br J Ophthalmol. 1997; 81:373-377.
129. Payant JA, Eggenberger LR, Wood TO. Electron microscopic findings in corneal epithelial basement membrane degeneration. Cornea. 1991;10:390-394.
130. Kenney MC, Nesburn AB, Burgeson RE, Butkowski RJ, Ljubimov AV. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea. 1997;16:345-351.
131. Tuori AJ, Virtanen I, Aine E, Kalluri R, Miner JH, Uusitalo HM. The immunohistochemical composition of corneal basement membrane in keratoconus. Curr Eye Res. 1997;16:792-801.
132. Sykakis E, Carley F, Irion L, Denton J, Hillarby MC. An in depth analysis of histopathological characteristics found in keratoconus. Pathology. 2012;44:234-239.
133. Hatchell DL, Magolan JJ Jr, Besson MJ, Goldman AI, Pederson HJ, Schultz KJ. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol. 1983; 101:469-471.
134. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt. 1988; 65:224-230.
135. Ljubimov AV, Huang ZS, Huang GH, et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem. 1998;46:1033-1041.
136. Azar DT, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Altered epithelial-basement membrane interactions in diabetic corneas. Arch Ophthalmol. 1992;110:537-540.
137. Kenney MC, Zorapapel N, Atilano S, Chwa M, Ljubimov A, Brown D. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro. Exp Eye Res. 2003;77:537-546.
138. Maseruka H, Ataullah SM, Zardi L, Tullo AB, Ridgway AE, Bonshek RE. Tenascin-cytotactin (TN-C) variants in pseudophakic/ aphakic bullous keratopathy corneas. Eye (Lond). 1998;12(pt 4):729-734.
139. Quantock AJ, Meek KM, Brittain P, Ridgway AE, Thonar EJ. Alteration of the stromal architecture and depletion of keratan sulphate proteoglycans in oedematous human corneas: histological, immunochemical and X-ray diffraction evidence. Tissue Cell. 1991;23:593-606.
140. Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM. Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy. Br J Ophthalmol. 2001;85:720-731.
141. Kenney MC, Chwa M, Alba A, Saghizadeh M, Huang ZS, Brown DJ. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998;17:238-246.
142. Kenney MC, Chwa M, Lin B, Huang GH, Ljubimov AV, Brown DJ. Identification of cell types in human diseased corneas. Cornea. 2001;20:309-316.
143. Alarcon I, Kwan L, Yu C, Evans DJ, Fleiszig SM. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect Immun. 2009;77: 3264-3271.
144. Huard J, Feero WG, Watkins SC, Hoffman EP, Rosenblatt DJ, Glorioso JC. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J Virol. 1996;70:8117-8123.
145. Romoser WS, Turell MJ, Lerdthusnee K, et al. Pathogenesis of Rift Valley fever virus in mosquitoes-tracheal conduits & the basal lamina as an extra-cellular barrier. Arch Virol Suppl. 2005;1:89-100.
146. Weeks BS, Ramchandran RS, Hopkins JJ, Friedman HM. Herpes simplex virus type-1 and-2 pathogenesis is restricted by the epidermal basement membrane. Arch Virol. 2000;145: 385-396.
147. Barbosa FL, Chaurasia SS, Kaur H, de Medeiros FW, Agrawal V, Wilson SE. Stromal interleukin-1 expression in the cornea after haze-associated injury. Exp Eye Res. 2010;91:456-461.
148. Kaur H, Chaurasia SS, Agrawal V, Suto C, Wilson SE. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1. Exp Eye Res. 2009;89:152-158.
149. Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res. 2006;82:788-797.
150. Mathew JH, Goosey JD, Bergmanson JP. Quantified histopathology of the keratoconic cornea. Optom Vis Sci. 2011;88: 988-997.